MONTELUKAST

montelukast 5 mg chewable tablet, 28

MONTELUKAST (8628D)

montelukast 5 mg chewable tablet, 28
8628D
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  6674

Indication: Asthma
Treatment phase: First-line prevention

Restriction  7781

Indication: Asthma
Treatment phase: Prevention of condition
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 28 # of repeats: 5 DPMQ: $18.09 Max safety net: $19.57 General Patient Charge: $22.36
Available brands
APX-MONTELUKAST
MONTELAIR 5
MONTELUKAST-WGR
Montelukast Lupin
Montelukast Sandoz 5
Montelukast Viatris